Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide + Lifestyle in Latinos with Obesity
NCT06009653Phase 4Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2023
- Primary completion
- May 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide in obesity, sponsored by Washington University School of Medicine. Planned start Sep 2023; status: withdrawn.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06009653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06009653.